MSLN and pancreatic neoplasm: Currently, the expression frequency of the msln protein in CRC samples was 40% (16 of 40 cases), 70% in ovarian cancer, 50% in lung cancer, and 46% in esophageal cancer, and in almost all mesothelioma and pancreatic cancer [1].